Cargando…

Closer to FREEDOM From Uncertainty

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Vaduganathan, Muthiah, Bikdeli, Behnood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American College of Cardiology Foundation. Published by Elsevier. 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150780/ https://www.ncbi.nlm.nih.gov/pubmed/37137585 http://dx.doi.org/10.1016/j.jacc.2023.03.407

Ejemplares similares

Acute Cardiovascular Complications of COVID-19: The High Risk of Underlying Heart Disease
por: Mensah, George A., et al.
Publicado: (2023)

Equality and Freedom as Uncertainty in Groups
por: Hoey, Jesse
Publicado: (2021)

Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence
por: Bikdeli, Behnood
Publicado: (2020)

To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question
por: Bikdeli, Behnood
Publicado: (2022)

Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes
por: Desai, Rishi J., et al.
Publicado: (2020)

Age of Data at the Time of Publication of Contemporary Clinical Trials
por: Welsh, John, et al.
Publicado: (2018)

Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries
por: Sumarsono, Andrew, et al.
Publicado: (2020)

Depression and quality of life in old age: a closer look
por: Hussenoeder, Felix S., et al.
Publicado: (2020)

Omega-3 Supplements and Cardiovascular Diseases
por: Mohebi-Nejad, Azin, et al.
Publicado: (2014)

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
por: Essien, Utibe R., et al.
Publicado: (2023)

Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016
por: Khera, Rohan, et al.
Publicado: (2020)

Physician Practice Pattern Variations in Common Clinical Scenarios Within 5 US Metropolitan Areas
por: Song, Zirui, et al.
Publicado: (2022)

Cardiac rupture after ST-elevation myocardial infarction (STEMI): a ‘Stitch’ in time?
por: Nagraj, Sanjana, et al.
Publicado: (2022)

Inferring Haplotypes of Copy Number Variations From High-Throughput Data With Uncertainty
por: Kato, Mamoru, et al.
Publicado: (2011)

Closer & closer apart : jealousy in literature
por: Lloyd, Rosemary
Publicado: (1995)

Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans
por: Lam, Carolyn S. P., et al.
Publicado: (2021)

Association of the New Peer Group–Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program
por: McCarthy, Cian P., et al.
Publicado: (2019)

Thromboprophylaxis strategies to improve the prognosis of COVID-19
por: Bertoletti, Laurent, et al.
Publicado: (2021)

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone
por: Agarwal, Rajiv, et al.
Publicado: (2023)

Interpreting Nonrandomized Evidence for Clinical Decision Making in Cardio-Oncology
por: Chatur, Safia, et al.
Publicado: (2023)

An Online Documentary Film to Motivate Quit Attempts Among Smokers in the General Population (4Weeks2Freedom): A Randomized Controlled Trial
por: Brown, Jamie, et al.
Publicado: (2016)

From Freedom From to Freedom To: New Perspectives on Intentional Action
por: Bonicalzi, Sofia, et al.
Publicado: (2019)

Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent
por: Dake, Michael D., et al.
Publicado: (2020)

Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis
por: Varshney, Anubodh S., et al.
Publicado: (2021)

Reply: Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients?
por: Bhatt, Ankeet S., et al.
Publicado: (2020)

A rationale for dedicated trials of combination therapy in heart failure
por: Blumer, Vanessa, et al.
Publicado: (2022)

Freedom in Teaching
por: Gibson, G. A.
Publicado: (1901)

Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990–2011
por: Bikdeli, Behnood, et al.
Publicado: (2017)

Freedom to think should not mean freedom from evidence and experience
por: Swann, Peter, et al.
Publicado: (2021)

Uncertainty of Prenatally Diagnosed Congenital Heart Disease: A Qualitative Study
por: Harris, Kelly W., et al.
Publicado: (2020)

COVID-19 Vaccine Myocarditis: Cautious Reassurance in an Era of Dynamic Uncertainty
por: Liu, Peter P., et al.
Publicado: (2022)

Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER
por: Desai, Akshay S., et al.
Publicado: (2022)

Freedom from substrate
por: Wells, William A.
Publicado: (2004)

Manual Thrombectomy in Myocardial Infarction: Aspiring for Better
por: Vaduganathan, Muthiah, et al.
Publicado: (2015)

What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction
por: Ostrominski, John W., et al.
Publicado: (2022)

Freedom of the will /
por: Edwards, Jonathan, 1703-1758
Publicado: (1969)

Freedom
Publicado: (1890)

Freedom /
por: Franzen, Jonathan

Addressing Equity and More in 2021: Call From Fellows-in-Training & Early Career Section Editors
por: Han, Jason J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_paafq0fi3epiqlavn2j8og0qiq